Assignee
MAPI PHARMA LTD
IL·23 granted patents·5 pending applications·48 citations·filing 2011–2025
Top patents by PatentIndex Score
28 records- 0191US11931357B2Depot systems comprising Cariprazine or salts thereofMAPI PHARMA LTD·Filed 2023·Granted Mar 19, 2024·2 cites·18 claims
- 0291US9006188B2Co-crystals of dapagliflozinMAPI PHARMA LTD·Filed 2014·Granted Apr 14, 2015·8 cites·15 claims
- 0390US11026908B2Extended release dosage forms of pregabalinMAPI PHARMA LTD·Filed 2017·Granted Jun 8, 2021·3 cites·10 claims
- 0490US9200114B2Random pentapolymer for treatment of autoimmune diseasesMAPI PHARMA LTD·Filed 2013·Granted Dec 1, 2015·8 cites·14 claims
- 0588US8377885B2Depot systems comprising glatiramer or pharmacologically acceptable salt thereofMAPI PHARMA LTD·Filed 2012·Granted Feb 19, 2013·14 cites·26 claims
- 0686USRE49251EDepot systems comprising glatiramer or pharmacologically acceptable salt thereofMAPI PHARMA LTD·Filed 2021·Granted Oct 18, 2022·1 cites·36 claims
- 0784US11865213B2Semaglutide depot systems and use thereofMAPI PHARMA LTD·Filed 2021·Granted Jan 9, 2024·1 cites·19 claims
- 0882US10493122B2Sublingual delivery of glatiramer acetateMAPI PHARMA LTD·Filed 2015·Granted Dec 3, 2019·5 cites·8 claims
- 0979US11471421B2Process for preparing microparticles containing glatiramer acetateMAPI PHARMA LTD·Filed 2017·Granted Oct 18, 2022·2 cites·19 claims
- 1077US12251380B2Depot systems comprising cariprazine or salts thereofMAPI PHARMA LTD·Filed 2024·Granted Mar 18, 2025·0 cites·20 claims
- 1177US11167003B2Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using sustained release glatiramer depot systemsMAPI PHARMA LTD·Filed 2018·Granted Nov 9, 2021·3 cites·20 claims
- 1277US2025352607A1Glatiramer depot systems for treating progressive forms of multiple sclerosisMAPI PHARMA LTD·Filed 2025·Application pending·0 cites
- 1375USRE50301EDepot systems comprising glatiramer or pharmacologically acceptable salt thereofMAPI PHARMA LTD·Filed 2022·Granted Feb 18, 2025·0 cites·35 claims
- 1471US8975244B2Process and intermediates for the preparation of abiraterone acetateMAPI PHARMA LTD·Filed 2014·Granted Mar 10, 2015·1 cites·18 claims
- 1570US12343371B2Method for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using a sustained release depot formulation comprising glatiramer acetateMAPI PHARMA LTD·Filed 2021·Granted Jul 1, 2025·0 cites·17 claims
- 1670US2024148653A1Semaglutide depot systems and use thereofMAPI PHARMA LTD·Filed 2023·Application pending·0 cites
- 1769US9453024B2Polymorphs of darunavirMAPI PHARMA LTD·Filed 2014·Granted Sep 27, 2016·0 cites·3 claims
- 1868US2021260006A1Extended release dosage forms of pregabalinMAPI PHARMA LTD·Filed 2021·Application pending·0 cites
- 1961US12097292B2Process for preparing microparticles containing glatiramer acetateMAPI PHARMA LTD·Filed 2022·Granted Sep 24, 2024·0 cites·20 claims
- 2061US9994522B2Amorphous form of apremilastMAPI PHARMA LTD·Filed 2014·Granted Jun 12, 2018·0 cites·20 claims
- 2159US9102592B2Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodiumMAPI PHARMA LTD·Filed 2014·Granted Aug 11, 2015·0 cites·4 claims
- 2257US12514908B2Semaglutide depot systems and use thereofMAPI PHARMA LTD·Filed 2022·Granted Jan 6, 2026·0 cites·15 claims
- 2351US2023256058A1Low burst-release liraglutide depot systemsMAPI PHARMA LTD·Filed 2021·Application pending·0 cites
- 2450US9096574B2Polymorphs of perampanelMAPI PHARMA LTD·Filed 2013·Granted Aug 4, 2015·0 cites·7 claims
- 2546US12370233B2Depot systems comprising glatiramer acetateMAPI PHARMA LTD·Filed 2017·Granted Jul 29, 2025·0 cites·12 claims
- 2641US10111867B2Process and intermediates for the preparation of perampanelMAPI PHARMA LTD·Filed 2015·Granted Oct 30, 2018·0 cites·21 claims
- 2738US2013046103A1Preparation of benzofurans and use thereof as synthetic intermediatesMAPI PHARMA LTD·Filed 2011·Application pending·0 cites
- 2835US9617241B2Intermediate compounds and process for the preparation of efinaconazoleMAPI PHARMA LTD·Filed 2015·Granted Apr 11, 2017·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when MAPI PHARMA LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →